Radiation Vasculopathy
Definition
Radiation vasculopathy refers to the spectrum of vascular injuries caused by ionising radiation to any vascular structure within the radiation field. It encompasses premature atherosclerosis (coronary and carotid artery disease), large- and medium-vessel stenosis, autonomic dysfunction, venous injury, and renal artery stenosis. More than 50% of cancer patients receive radiotherapy, making radiation vasculopathy one of the most prevalent long-term cardiovascular complications in cancer survivors.
Key Concepts
Mechanisms
- Acute vascular injury: Endothelial dysfunction, inflammatory infiltration, and radiation injury to the vasa vasorum occur during and immediately after treatment — initiating a persistent cycle of microvasculature and conduit artery damage. (sources/cardio-oncology-vascular-metabolic-aha-2019 — very high)
- Chronic remodelling: Ongoing inflammation, smooth muscle proliferation, and adventitial fibrosis progress over years to decades after treatment, producing premature atherosclerosis that is morphologically similar to conventional atherosclerosis but develops at younger ages and in atypical distributions. (sources/cardio-oncology-vascular-metabolic-aha-2019)
Clinical Manifestations by Radiation Field
- Mediastinal/cardiac RT (Hodgkin lymphoma, breast cancer):
- Premature CAD — linear dose-response relationship; no safe lower threshold established.
- Pericardial disease (pericarditis, constrictive pericarditis).
- Valvular heart disease (fibrosis, most commonly left-sided).
- Cardiomyopathy (restrictive or dilated). (sources/cardio-oncology-vascular-metabolic-aha-2019 — very high)
- Head/neck RT:
- Significantly increased carotid disease, TIA, and ischaemic stroke risk. (sources/cardio-oncology-vascular-metabolic-aha-2019)
- Large/medium vessel:
- Axillary artery stenosis (breast RT), porcelain aorta (mediastinal RT).
- DVT, venous stenosis, and renal artery stenosis from non-selective field exposure. (sources/cardio-oncology-vascular-metabolic-aha-2019)
- Autonomic dysfunction (cranial/neck/mediastinal RT):
- Labile BP and HR, orthostatic intolerance, impaired heart rate recovery.
- Hodgkin lymphoma survivors (n=263, median 19 years post-RT): 4× higher resting HR, 5× higher rate of abnormal heart rate recovery (HRR) after exercise, 4-fold increased all-cause mortality with abnormal HRR. (sources/cardio-oncology-vascular-metabolic-aha-2019 — very high)
Surveillance Recommendations
- Expert groups recommend stress testing 5–10 years post-mediastinal RT, then every 5 years.
- Carotid ultrasound surveillance after head/neck RT.
- Cardiac imaging if functional symptoms develop. (sources/cardio-oncology-vascular-metabolic-aha-2019)
Outcomes After Vascular Intervention
- Outcomes of percutaneous coronary intervention (PCI), coronary artery bypass grafting (CABG), and carotid endarterectomy are inferior to non-irradiated cohorts — higher in-stent restenosis, poorer vein graft patency, and more fibrous/calcified tissue limiting technical success. (sources/cardio-oncology-vascular-metabolic-aha-2019)
Prevention and Dose Reduction
- Lower cumulative radiation dose, cardiac shielding, tangential beam fields, 3D image-guided planning, and respiratory gating reduce cardiac and vascular dose while maintaining tumour control. (sources/cardio-oncology-vascular-metabolic-aha-2019)
- Proton beam therapy delivers lower entrance/exit dose to adjacent structures — increasingly used for mediastinal malignancies with curative intent, where long-term cardiac morbidity is most clinically relevant.
Contradictions / Open Questions
- No safe radiation dose established: The dose-response relationship for premature CAD is linear without a clear safe threshold. Balancing tumour control with vascular dose reduction requires individualised planning. (sources/cardio-oncology-vascular-metabolic-aha-2019)
- Surveillance interval evidence gap: Recommended surveillance intervals (stress testing every 5 years post-mediastinal RT) are expert-derived, not from prospective RCTs. Optimal surveillance frequency and modality are not standardised. (sources/cardio-oncology-vascular-metabolic-aha-2019)
- Intervention outcomes inferior — mechanical vs. biological factors: Whether worse PCI/CABG outcomes reflect fibrous/calcified vascular pathology, radiation-impaired healing, or both is incompletely characterised. (sources/cardio-oncology-vascular-metabolic-aha-2019)
Connections
- Related to concepts/Cancer-Therapy-Related-CV-Toxicity
- Related to concepts/Cardio-Oncology
- Related to concepts/Coronary-Vasospasm
- Related to concepts/Coronary-Microvascular-Dysfunction
- Related to entities/Coronary-Artery-Disease